BRIEF-Transgene shares rise 5 pct after "promising" cancer treatment tests

PARIS Wed May 28, 2014 3:02am EDT

Related Topics

PARIS May 28 (Reuters) - Transgene SA : * Shares rise 5 percent after announced promising results in an update incorporating more mature data from the Phase 2b part of the Phase 2b/3 TIME trial1 with TG4010 MUC-1 targeted immunotherapy in patients with advanced non-small cell lung cancer

FILED UNDER: